Pediatric Emergency Department (ED) visits for firearm injuries doubled during the pandemic compared to earlier trends, according to a multicenter study published in the journal Pediatrics. During this time, deaths from firearm ...
Nov 6, 2023
0
0
A new analysis indicates that county-level structural racism is a significant determinant of death among individuals with kidney failure. The research will be presented at ASN Kidney Week 2023 November 1–5.
Nov 3, 2023
0
0
Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality health care is equal, regardless of socioeconomic status. ...
Oct 27, 2023
0
0
White people who visit hospital emergency departments with pain are 26% more likely than Black people to be given opioid pain medications such as morphine. This was a key finding from our recent study, published in the Journal ...
Oct 27, 2023
0
0
New research by Nemours Children's Health has found that teens who are Black, publicly insured and of lower socioeconomic status (SES) tend to have more major complications after surgery for adolescent idiopathic scoliosis ...
Oct 26, 2023
0
0
A new study presented today at the Transcatheter Cardiovascular Therapeutics (TCT) conference 2023 sought to evaluate the presence of racial, ethnic, and socioeconomic inequities in access to mechanical circulatory support ...
Oct 25, 2023
0
1
Older Black Americans are more likely to receive low-value acute diagnostic tests than older white Americans, while older white Americans were more likely to receive low-value screening tests and treatments, finds a study ...
Oct 25, 2023
0
0
Heather Avant always dresses up when she goes to the emergency room.
Oct 23, 2023
0
0
A retrospective analysis of pediatric sepsis deaths at a large hospital in Arkansas found that Black children in the hospital were 2.5 times more likely to die of sepsis than white patients, according to research presented ...
Oct 20, 2023
0
0
Patients with multiple myeloma treated with idecabtagene vicleucel, known as "ide-cel," a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of race and ethnicity, according ...
Oct 19, 2023
0
1
